Creso Pharma Limited advised that it has completed all required importing and exporting procedures and successfully delivered a second shipment of cannaQIX® products to the subsidiary of Lupin International, Pharma Dynamics South Africa. cannaQIX® is Creso Pharma's range of cannabidiol (CBD) hemp oil-based nutraceuticals, which contains a broad spectrum of organic hemp oil extracts with CBD that aims to improve management of stress and to support mental and nervous functions. Delivery follows the receipt of a second purchase order ("PO") from Pharma Dynamics in October 2020 valued at CHF 220,000 (~AUD 320,000), which has now been banked and adds to Creso Pharma's growing revenue profile. The delivery of the second purchase order follows the Company's successful launch into the South African market in collaboration with Pharma Dynamics. Pharma Dynamics launched the cannaQIX® regular products during second quarter 2020 and is marketing it under the 'Cannamics' brand.